LA JOLLA, Calif., Nov. 3 /PRNewswire/ -- Advanced Tissue Sciences, Inc.
(Nasdaq: ATIS) will announce its third-quarter 2000 results on Tuesday,
November 7, 2000.
A conference call will be held on Monday, November 13, 2000, at 11:00 a.m.
Eastern Standard Time (EST) to discuss the Company's financial results and
other recent developments and to answer questions from analysts. To
participate in the conference call from the United States, please dial
(800) 777-4529; international callers, please dial (212) 896-6070; all callers
should ask to be connected to the Advanced Tissue Sciences investor call.
A continuous replay of the call will be available after the conclusion of
the call until 8:00 p.m. EST on Friday, November 17, 2000. To listen to the
replay, please dial (800) 633-8284. International callers, please dial
(858) 812-6440. The reservation number that you will need to access the
replay is 16851156.
Additionally, you may listen to the conference call over the Internet by
visiting our web site at http://www.advancedtissue.com. For those who cannot listen
to the live broadcast, a replay will be available on our web site until 8:00
p.m. EST on Friday, November 17, 2000.
Techvest, LLC's Tissue Engineering Conference
In addition to the release of the third-quarter results and conference
call, Advanced Tissue Sciences is scheduled to present at the Second Annual
Conference on Tissue Repair Replacement and Regeneration sponsored by
Techvest, LLC. The meeting will be held at the New York Marriott East Side
Hotel on November 8-9, 2000. Art Benvenuto, Chairman and Chief Executive
Officer, and Gail K. Naughton, Ph.D., President, will present an overview of
the Company's business strategy and programs on Wednesday, November 8, 2000 at
10:30 a.m. EST.
You may view and listen to the presentation over the Internet by visiting
our web site at http://www.advancedtissue.com. For those who cannot listen to the
live broadcast, a replay will be available on our web site until 8:00 p.m. EST
on Wednesday, November 15, 2000.
Advanced Tissue Sciences is a tissue engineering company utilizing its
proprietary core technology to develop and manufacture human-based tissue
products for tissue repair and transplantation. The Company has two joint
ventures with Smith & Nephew plc. The first covers the application of
Advanced Tissue Sciences' tissue engineering technology for skin wounds and
includes Dermagraft(R) for the treatment of diabetic foot ulcers,
TransCyte(TM) for the temporary covering of second and third-degree burns and
future developments for venous ulcers, pressure ulcers, burns and other non-
aesthetic wound care treatments. The second joint venture is developing
tissue-engineered orthopedic cartilage, initially focusing on the repair of
cartilage in knee joints. The Company also has a strategic alliance with
Inamed Corporation for the development and marketing of several of Advanced
Tissue Sciences' human-based, tissue-engineered products for aesthetic and
certain reconstructive applications. In addition, the Company is developing
products for cardiovascular applications. For more information on Advanced
Tissue Sciences visit our web site at http://www.advancedtissue.com.
SOURCE Advanced Tissue Sciences, Inc.
 back to top
Related links:
http://www.advancedtissue.com
Company News On-Call:
http://www.prnewswire.com/comp/532975.html or fax,
800-758-5804, ext. 532975
CONTACT:
Jana Stoudemire, Senior Director, Corporate
Communications of Advanced Tissue Sciences, Inc., 858-713-7802
|
